Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy

Table 1 Clinical characteristics of the 30 patients in the transplantation group

No.	Gender	GMFCS stage	Age (years)	LDQ	GMFM
1	Female	V	1	72	36
2	Female	III	3	31.7	176
3	Male	III	4	28	189
4	Male	III	4	92	185
5	Male	V	3	100	50
6	Male	IV	2	38	101
7	Male	V	4.5	15	23
8	Male	IV	4	26.8	115
9	Female	V	3	75	42
10	Female	IV	13	82	105
11	Female	V	1.5	62	38
12	Male	V	1	70	31
13	Female	V	1	75	20
14	Male	IV	2	90	63
15	Male	III	4	98	191
16	Female	IV	3	30	96
17	Male	IV	21	80	82
18	Female	III	2	98	120
19	Male	IV	5	85	86
20	Female	III	8	10	115
21	Female	III	4	90	183
22	Female	V	5	10	23
23	Female	III	12	100	195
24	Male	IV	2	98	83
25	Male	V	1	15	12
26	Female	III	6.5	90	193
27	Female	III	4	92	196
28	Female	IV	32	73	117
29	Female	V	1	54	56
30	Male	III	8.5	97	201

The clinical characteristics of the 30 patients in the transplantation group before the cell transplantation treatment are shown. GMFCS: Gross Motor Function Classification System levels; LDQ: language developmental quotient; GMFM: Gross Motor Function Measurement scores.

ISSN: 1479-5876